New York Life Investment Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.12M Buy
58,704
+543
+0.9% +$47.4K 0.05% 324
2025
Q1
$3.97M Sell
58,161
-445
-0.8% -$30.4K 0.04% 366
2024
Q4
$4.56M Sell
58,606
-600
-1% -$46.7K 0.04% 345
2024
Q3
$3.97M Sell
59,206
-1,338
-2% -$89.7K 0.04% 411
2024
Q2
$6.86M Buy
60,544
+2,211
+4% +$251K 0.07% 256
2024
Q1
$8.09M Sell
58,333
-2,141
-4% -$297K 0.08% 226
2023
Q4
$7.5M Sell
60,474
-118
-0.2% -$14.6K 0.08% 226
2023
Q3
$5.65M Sell
60,592
-245
-0.4% -$22.9K 0.06% 284
2023
Q2
$7.82M Sell
60,837
-172
-0.3% -$22.1K 0.08% 230
2023
Q1
$7.09M Sell
61,009
-124
-0.2% -$14.4K 0.08% 256
2022
Q4
$6.92M Sell
61,133
-1,014
-2% -$115K 0.08% 253
2022
Q3
$5.01M Sell
62,147
-420
-0.7% -$33.8K 0.06% 307
2022
Q2
$4.66M Buy
+62,567
New +$4.66M 0.05% 324